Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Other hematologic neoplasm 1Other 1Lymphoid 1Gastrointestinal 1

Conditions

Vitamin D Deficiency 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 168Rituximab 161Specimen Handling 115Biopsy 91Magnetic Resonance Spectroscopy 89Vincristine 84Doxorubicin 78Prednisone 75fludarabine 71venetoclax 69obinutuzumab 62ibrutinib 55Lenalidomide 55Dexamethasone 55Cytarabine 48Methotrexate 47acalabrutinib 43Etoposide 41CT-P10 41blinatumomab 40fludarabine phosphate 35Gemcitabine 33Bendamustine Hydrochloride 33zanubrutinib 31pembrolizumab 30glofitamab 30Calcium Dobesilate 30prednylidene 29deltacortene 28Nivolumab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholecalciferol × Lymphoid × 90 days × Clear all
NCT02553447 2026-04-21

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

University of Nebraska

Phase NA Completed
197 enrolled 15 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Vitamin D Deficiency, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡